“Lemdesivir reduces the corona treatment period by 31%”

[코로나19 팬데믹]National infectious disease in the US USA “It takes an average of 11 days”
The FDA appears to announce approval for emergency use … US actions. USA They run 2% and international oil prices are strong
Remedyvir, which is expected as a treatment for the new coronavirus infection (Corona19), has been shown to reduce the treatment period by 31%. As a result, it was predicted that the Food and Drug Administration (FDA) would announce approval of the emergency use of Remdesivir. In anticipation of the appearance of the Corona19 treatment, the US stock market. USA It rose more than 2% and international oil prices strengthened.

According to the National Institutes of Health (NIH) on the 29th of last month (local time), the recovery period for Corona19 patients who prescribed Remedyvir in a clinical trial conducted by the National Institute of Allergic Diseases (NIAID) on Corona19 patients throughout The world was found to be 31% faster than the false group (placebo) prescription group, which is an average of 11 days and 15 days. “Although it is not perfect, it showed us that it can be used as a remedy,” said Anthony Pouch, director of NIAID. The mortality rate, the relationship between the number of deaths and the number of patients, was also 8.0% in the remedyvir prescription group, lower than the placebo prescription group (11.6%).

Although it has not yet been released as a document after a peer review, specific data is expected to be released as the exchange director says: “It will be the standard for corona19 treatment in the future.” The media, such as the New York Times (NYT), quoted senior officials from the US administration. USA And they reported that Remdesivir will soon be approved by the FDA for use in patients.

However, on the same day, the British medical journal “Lancet” showed a contrast by publishing an article that showed little difference in virus reduction or mortality in a clinical trial on Lemdesivir in 237 severely corona19 patients in China. For dosing within 10 days of symptom onset, the mortality rate decreased slightly, but was unclear, so a large-scale clinical trial was needed.
Meanwhile, the global financial market applauded the results of Remdesivir’s clinical trials. On this day, the shares of the US Dow Jones Industrial Average. USA They traded at 24,633.86, an increase of 2.21% from the previous trading day. The Standard & Poor’s (S & P) 500 Index was up 2.66% and the Nasdaq Index was up 3.57%. International oil prices, which had been weak, became strong. In June, crude oil futures in the western US USA (WTI) were trading at $ 15.06 per barrel, 22.04% more than the previous trading day. This is because it is reflected in the expectation that if Corona treatment is guaranteed19, the containment of countries around the world will rise and the economy will normalize rapidly.

Reporter Shin Shin-young, reporter for Dong-A Sciences [email protected]